Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TERT | O14746 | 1/20 | 0.43 |
| ▸ | DPP4 | P27487 | 13/20 | 0.41 |
| ▸ | DPP8 | Q6V1X1 | 8/20 | 0.41 |
| ▸ | DPP9 | Q86TI2 | 7/20 | 0.41 |
| ▸ | MME | P08473 | 1/20 | 0.38 |
| ▸ | ACE | P12821 | 1/20 | 0.38 |
| ▸ | CPA1 | P15085 | 1/20 | 0.38 |
| ▸ | ACE2 | Q9BYF1 | 1/20 | 0.38 |
| ▸ | DPP7 | Q9UHL4 | 7/20 | 0.37 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12259750 | 0.83 | TERT (0.46) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL3667413 | 0.83 | TERT (0.46) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL25327755 | 0.81 | DPP4 (0.45) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL8260358 | 0.80 | TERT (0.43) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL19919650 | 0.80 | TERT (0.43) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL8533422 | 0.80 | TERT (0.43) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL7273950 | 0.80 | CYP2D6 (0.45) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL25328845 | 0.79 | SPHK1 (0.36) | DPP4DPP8DPP9DPP7 | |
| SCHEMBL23071543 | 0.78 | TERT (0.43) | TERTDPP4DPP8DPP9MME | |
| SCHEMBL3160851 | 0.78 | TERT (0.43) | TERTDPP4DPP8DPP9MME |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230234912-A1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | APICAL MOLECULAR BIOTECH CO., LTD. (TW) | 2023-07-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230234912-A1 | NOVEL ANALOGS OF PTEROSTILBENE AMINO ACID BEARING CARBONATES FOR TREATING A NON-ALCOHOLIC FATTY LIVER DISEASE AND NONALCOHOLIC STEATOHEPATITIS | FABP1, GLS2, SLC1A5 | TERT 3628/4885DPP4 1225/4885DPP8 275/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.